Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase Ib Trial of Pembrolizumab (MK-3475) With Platinum-Based Chemotherapy in Small Cell/Neuroendocrine Cancers of Urothelium and Prostate

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03582475
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:59.093915+00:00
Published At
2025-06-10T00:00:00+00:00
Record Updated At
2025-11-12
Results Posted At
2025-06-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Bladder Small Cell Neuroendocrine Carcinoma", "Castration-Resistant Prostate Carcinoma", "Metastatic Bladder Urothelial Carcinoma", "Metastatic Urethral Urothelial Carcinoma", "Prostate Carcinoma Metastatic in the Bone", "Prostate Neuroendocrine Neoplasm", "Prostate Small Cell Carcinoma", "Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8", "Stage III Prostate Cancer AJCC v8", "Stage III Urethral Cancer AJCC v8", "Stage IV Bladder Cancer AJCC v8", "Stage IV Prostate Cancer AJCC v8", "Stage IV Urethral Cancer AJCC v8", "Stage IVA Bladder Cancer AJCC v8", "Stage IVB Bladder Cancer AJCC v8", "Ureter Small Cell Carcinoma", "Urothelial Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-12"
protocolSection.identificationModule.nctId
"NCT03582475"
protocolSection.identificationModule.officialTitle
"Phase Ib Trial of Pembrolizumab (MK-3475) With Platinum-Based Chemotherapy in Small Cell/Neuroendocrine Cancers of Urothelium and Prostate"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-06-10"

Study condition terms

  • Bladder Small Cell Neuroendocrine Carcinoma (protocolSection.conditionsModule.conditions)
  • Castration-Resistant Prostate Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Bladder Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Urethral Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Prostate Carcinoma Metastatic in the Bone (protocolSection.conditionsModule.conditions)
  • Prostate Neuroendocrine Neoplasm (protocolSection.conditionsModule.conditions)
  • Prostate Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8 (protocolSection.conditionsModule.conditions)
  • Stage III Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Urethral Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Prostate Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Urethral Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Bladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Ureter Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Urothelial Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.